Status:
TERMINATED
Multi-catheter High Dose Rate (HDR) Breast Brachytherapy
Lead Sponsor:
University of Wisconsin, Madison
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
PHASE2
Brief Summary
Breast conservation therapy (BCT) is now widely accepted as a treatment option for most women with Stage I and II invasive breast cancer and most patients with ductal carcinoma in situ (DCIS). Despite...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Invasive breast cancer or DCIS, tumor stage of Tis, T1, T2 if lesion is \< 3 cm, N0 or N1 if 1-3 + nodes with no extracapsular extension
Exclusion
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2010
Estimated Enrollment :
127 Patients enrolled
Trial Details
Trial ID
NCT00214149
Start Date
October 1 2004
End Date
October 1 2010
Last Update
November 5 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Wisconsin Hospital and Clinics
Madison, Wisconsin, United States, 53792